Exploring Analyst Estimates for MetLife (MET) Q1 Earnings, Beyond Revenue and EPS
π’ Wall Street analysts project MetLife (MET) quarterly earnings at $2.23 per share, representing a 13.8% year-over-year increase.
π° Consensus revenue estimates for MetLife stand at $19.2 billion, reflecting a 2% growth compared to the prior-year quarter.
π The consensus EPS estimate has been revised downward by 1.2% over the past 30 days as analysts reassess forecasts.
π Analysts expect MetLife's 'Revenue-Premiums' to reach $11.49 billion, marking a 2% decline from the year-ago quarter.
π΅ 'Revenue-Other Revenues' are projected at $705.48 million, indicating a 2.7% year-over-year increase.
πΌ Policy fees related to universal life and investment-type products are estimated at $1.29 billion, up 5.2% year-over-year.
π Net investment income is forecasted to hit $5.68 billion, driven by a strong 16.3% year-over-year increase.
π Adjusted Revenue for Latin America is expected to reach $2.17 billion, showing a 13.2% year-over-year gain.
π’ Corporate & other net investment income is predicted at $1.08 billion, representing a massive 1425.8% increase from the prior quarter.
π EMEA adjusted revenue totals are projected at $807.11 million, up 11.2% year-over-year.
π Asia total adjusted revenue is estimated at $3.14 billion, reflecting an 8.9% year-over-year increase.
π° Asia net investment income specifically is forecasted at $1.41 billion, a 16.8% rise from the prior-year quarter.
π EMEA net investment income is expected to reach $66.84 million, up 15.2% year-over-year.
π΅ Latin America net investment income is projected at $456.73 million, indicating a 12.2% year-over-year increase.
π MetLife shares have gained 13.3% over the past month, outperforming the S&P 500 composite's 10.5% gain.
π MET currently holds a Zacks Rank #3 (Hold), suggesting it may mirror overall market performance in the near term.
- MetLife analysts project quarterly earnings of $2.23 per share, representing an impressive 13.8% year-over-year increase.
- Revenue is expected to reach $19.2 billion, marking a 2% growth from the same quarter last year.
- 'Net investment income' is forecasted to surge by 16.3% year over year to $5.68 billion.
- 'Adjusted Revenue- Asia- Net investment income' shows robust growth with a projected increase of +16.8% year over year.
- 'Total Adjusted Revenue- Latin America' is estimated to grow by +13.2%, reaching $2.17 billion.
- 'Adjusted Revenue- Corporate & other- Net investment income' displays exceptional momentum with a year-over-year change of +1425.8%.
- MetLife shares have delivered +13.3% returns over the past month, outperforming the S&P 500 composite's +10.5% gain.
- Multiple revenue segments demonstrate strong double-digit growth, including 'Revenue- Universal life and investment-type product policy fees' at +5.2%.
- Wall Street analysts have collectively revised their EPS consensus estimates downward by 1.2% for MetLife (MET) over the past 30 days, signaling a bearish reassessment of the company's earnings potential before its quarterly report.
- Analysts project that 'Revenue- Premiums' will decline by 2% year-over-year to $11.49 billion, indicating weakness in one of the key revenue streams for MetLife.
- MetLife's stock is currently assigned a Zacks Rank #3 (Hold), suggesting analysts do not see strong near-term upside and expect the stock to merely mirror overall market performance rather than outperform.
- The significant 495% year-over-year increase in 'Adjusted Revenue- Corporate & other- Net investment income' ($1.08 billion) may mask underlying operational struggles or one-off items that could inflate current earnings estimates without reflecting sustainable growth.